Digital pathology is more than simple image viewing and evaluation. It is about streamlining case management by exploiting advances in image digitisation and solution interoperability to ensure the accelerated return of patient results.

The SYNAPSE Pathology is a vendor-agnostic workflow driven, case management and image visualisation technology, which sits at the centre of an end-to-end Digital Pathology Solution from Fujifilm.

Whole Slide Image Scanning

SYNAPSE Pathology integrates with leading manufacturers of whole slide image (WSI) scanners empowering customers to arrive at their preferred blend of scanner technologies based on their most important use-cases, current and projected case throughput volumes, and laboratory workspace considerations.

Image Analysis Solutions

SYNAPSE Pathology offers productised integrations, comprehensive software development kits (SDK) and an open API.

Information Systems

SYNAPSE Pathology affords a seamless bi-directional message exchange with the Laboratory Information Systems (LIMS) and reporting system.

Your Workflow Solution

Is your lab open to accelerated diagnoses?

FUJIFILM Corporation recently announced the company has entered into an asset purchase agreement to acquire the global digital pathology business of Tampa, Florida-based Inspirata, Inc. Upon completion of this agreement, Inspirata's Dynamyx® digital pathology technology, employees and customers will become part of Fujifilm. The addition of digital pathology will expand Fujifilm’s robust Synapse® Enterprise Imaging offering to enable the integration of pathology images and data into a healthcare organization’s electronic health record system and help to streamline care delivery for oncology patients and provider teams.

Building off the success of its established partnership with Inspirata, this acquisition marks Fujifilm’s full-scale, global entry into the largely unpenetrated digital pathology market, where 85% of U.S., 86% of European, and 90% of Asian healthcare organizations are still running on analog.

“Acquiring Inspirata’s digital pathology business allows Fujifilm to be an even stronger healthcare partner – bridging a technological gap between pathology, radiology and oncology to facilitate a more collaborative approach to care delivery across the enterprise,” says Teiichi Goto, president and CEO, representative director, FUJIFILM Corporation. “We’re thrilled to welcome Inspirata’s digital pathology experts to Fujifilm’s growing medical informatics business, along with their renowned global customer base, as together we work to drive the digitization and advancement of healthcare.”

Follow us on

Please refer to the operator manual/Instructions for use and the related documents for appropriate use of this product.
© 2023 FUJIFILM Healthcare Europe Holding AG. All trade marks are the property of Fujifilm Corporation